ADAMTS13 and thrombotic thrombocytopenic purpura: The propeptide metalloprotease domain is reported to function as a molecular safeguard of ADAMTS13 and does not affect the enzymatic action of the protein or its expression levels [28], and it also detected IgG antibodies binding the propeptide domain in 20% of acquired TTP plasma samples [7].